Pulmonary Fibrosis News

Pulmonary Fibrosis News We are dedicated to sharing the latest news, research, and pulmonary fibrosis patient perspectives.

The FDA approved Boehringer's nerandomilast, now Jascayd, as the first new U.S. treatment for idiopathic pulmonary fibro...
10/08/2025

The FDA approved Boehringer's nerandomilast, now Jascayd, as the first new U.S. treatment for idiopathic pulmonary fibrosis in over 10 years. https://buff.ly/4pXWzaI

Columnist Sam Kirton explains why you should consider attending the Pulmonary Fibrosis Foundation Summit 2025 in Chicago...
10/07/2025

Columnist Sam Kirton explains why you should consider attending the Pulmonary Fibrosis Foundation Summit 2025 in Chicago, Nov. 13-15. https://buff.ly/kJBqEoe

Nerandomilast appears to reduce the risk of death in people with IPF and PPF, according to analyses of clinical trial da...
10/01/2025

Nerandomilast appears to reduce the risk of death in people with IPF and PPF, according to analyses of clinical trial data. https://buff.ly/iJA0h26

🌍 Today on  , we join the global community in raising awareness for lung health.For people living with cystic fibrosis, ...
09/25/2025

🌍 Today on , we join the global community in raising awareness for lung health.

For people living with cystic fibrosis, protecting and maintaining lung function is central to everyday life. From treatments and therapies to the power of community support, every step matters in the journey toward healthier lungs.

For columnist Sam Kirton, Pulmonary Fibrosis Awareness Month is an opportunity to tell others about his journey. https:/...
09/23/2025

For columnist Sam Kirton, Pulmonary Fibrosis Awareness Month is an opportunity to tell others about his journey. https://buff.ly/ZGx9yNt

Connect today: http://bit.ly/46yglo0September is Pulmonary Fibrosis Awareness Month! đź’™If you or a loved one is navigatin...
09/23/2025

Connect today: http://bit.ly/46yglo0

September is Pulmonary Fibrosis Awareness Month! đź’™

If you or a loved one is navigating a lung disease like pulmonary fibrosis, you don’t have to do it alone. The American Lung Association’s Lung Health Navigators are health experts — nurses, respiratory therapists, and certified specialists — offering free, one-on-one support.

They can help you understand your diagnosis, explore treatment options, find specialists, and manage daily challenges. Support is available in English, Spanish, and over 250 languages!

American Lung Association

GRI-0621, an experimental oral therapy for IPF, may stabilize lung function, according to an interim analysis of an ongo...
09/17/2025

GRI-0621, an experimental oral therapy for IPF, may stabilize lung function, according to an interim analysis of an ongoing trial. https://buff.ly/gldN0vV

As she plans her return to university teaching, columnist Ann Reynoso realizes how PF has given her a range of new skill...
09/16/2025

As she plans her return to university teaching, columnist Ann Reynoso realizes how PF has given her a range of new skills for the classroom. https://buff.ly/DJtPk8b

Feeling overwhelmed or isolated with pulmonary fibrosis? That’s exactly why Pulmonary Fibrosis News exists: t.mtrbio.com...
09/16/2025

Feeling overwhelmed or isolated with pulmonary fibrosis? That’s exactly why Pulmonary Fibrosis News exists: t.mtrbio.com/pulmonary-fibrosis-news

What you’ll find at PulmonaryFibrosisNews.com:

• 📰 Timely updates on the latest PF news and research
• 💬 Thoughtful perspectives from real PF advocates
• 📚 Resource articles on treatment, symptom management, and support
• 🤝 Forums to connect with others living with or caring for someone with PF
• ✨ Highlights featuring our newest articles, videos, news, and more

Whether you’re looking for information, community, or support, we’re here every step of the way. Visit the site to get started!

Using a specialized lab technique, scientists identified early cellular changes that may help drive lung scarring in pul...
09/10/2025

Using a specialized lab technique, scientists identified early cellular changes that may help drive lung scarring in pulmonary fibrosis. https://buff.ly/Gr5V4mz

Tyvaso significantly improved a measure of lung function for IPF patients in a Phase 3 trial, which top-line data showed...
09/03/2025

Tyvaso significantly improved a measure of lung function for IPF patients in a Phase 3 trial, which top-line data showed met its main goal. https://buff.ly/THeLpk5

September is Pulmonary Fibrosis Awareness Month, and advocates are hoping to call attention to the condition and interst...
08/27/2025

September is Pulmonary Fibrosis Awareness Month, and advocates are hoping to call attention to the condition and interstitial lung diseases. https://buff.ly/biBgaGS

Address

5307 E Mockingbird Lane
Dallas, TX
75206

Alerts

Be the first to know and let us send you an email when Pulmonary Fibrosis News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

JOIN THE PF FORUMS!

WHY YOU SHOULD CONSIDER JOINING OUR ONLINE FORUM?

It’s a safe community to connect with other patients.

You can get comprehensive updates on PF in one place.

We welcome physicians and researchers, patients and caregivers.